Team Lifestyle Immersion Hypertension Control Project
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Meharry Medical College
- Study ID
- NCT07201948
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 30 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- Lifestyle Immersion Intervention that will address Nutrition, Physical Fitness, and BP Self-Monitoring3 Elements: — BEHAVIORAL1. : Two distinct groups will be enrolled: * Those diagnosed with hypertension: BP \>=140/90, within the last 2 years. * Those with BP \>=130/80. Not yet diagnosed with hypertension. 2. . Intervention: Comprehensive and integrated intervention components * Implemented by 3 certified experts (Dietician, Fitness Trainer, Cardiologist) * Modules: Education, Demonstration, Practical skill development sessions. 3. . Intervention is based on American Hearts Association Life's Simple 7. The nutrition aspect will follow the DASH Diet plan.
Study Details
This project is focuses on reducing the risk and progression of hypertension among a population that records high incidence of hypertension and other chronic ailments such as heart disease, diabetes, kidney failure, and obesity, with similar control measures. Several clinical trials over the last five decades have emphasized the importance of supportive lifestyle modification in the control of chronic disease that include a healthy diet, physical activity, quitting tobacco use, reducing alcohol use to the minimum, self-management of the disease, and adequate sleep. Study participants will receive motivation and skill development support in additional to specific nutrition, physical fitness, and self-management counselling from certified experts. This intervention incorporates elements of the American Heart Association prescription for health, Life's Simple 7 (LS7) lifestyle modification, the Dietary Approaches to preventing Hypertension (DASH) eating plan. After receiving these interventions, participants will be contacted at 3-months, 6-months, and 12-months for follow-up. They will complete similar surveys to be compared to determine impact on their hypertension. This intervention is complementary to usual pharmaceutical hypertension management.
Key Dates
- Start date
- Jun 1, 2025
- Status verified
- Mar 2025
- Primary completion
- Dec 30, 2027
- Completion
- Apr 30, 2028
Study Design
- Enrollment
- 220 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Active Comparator: Team Group4-6 participants will be assigned to a Team. They will be instructed to work together and motivate each other to adhere to the intervention components, to attend intervention activities, and meet lifestyle modification goals. They will receive the intervention knowledge and skills training from: * Dietician * Physical Fitness Trainer * cardiologist They will also receive other support to enhance their lifestyle immersion from the research team.
- Active Comparator: Individual GroupIndividual participants will be instructed to self-motivate to adhere to the intervention components, to attend intervention activities, and meet lifestyle modification goals. They will receive the intervention knowledge and skills training from: * Dietician * Physical Fitness Trainer * cardiologist They will also receive other support to enhance their lifestyle immersion from the research team.
Primary Outcome Measure
Systolic and Diastolic Blood Pressure Change [ Time Frame: 6 months & 12 months. ]
Central Contacts
- Flora Ukoli, MD, MPH16153275653
- Adrian Samuels, Ph.D.1615-207-8382
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Meharry Medical College | Nashville | Tennessee | 37208-3501 | Adrian Samuels, Ph.D. Chike Nzerue, MD (SUB_INVESTIGATOR) |
Find similar trials in Nashville, TN
Related Studies
- Metabolic Effects of Angiotensin-(1-7)PHASE1 · Recruiting · Vanderbilt University · Nashville, Tennessee
- Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine HypertensionRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona